Literature DB >> 21165516

Antiproliferative activity of chelating N,O- and N,N-ruthenium(II) arene functionalised poly(propyleneimine) dendrimer scaffolds.

Preshendren Govender1, Anna K Renfrew, Catherine M Clavel, Paul J Dyson, Bruno Therrien, Gregory S Smith.   

Abstract

Chelating neutral (N,O) and cationic (N,N) first- and second-generation ruthenium(II) arene metallodendrimers based on poly(propyleneimine) dendrimer scaffolds were obtained from dinuclear arene ruthenium precursors by reactions with salicylaldimine and iminopyridyl dendritic ligands, respectively. The N,N cationic complexes were isolated as hexafluorophosphate salts and were characterised by NMR and IR spectroscopy, and MALDI-TOF mass spectrometry. Related mononuclear complexes were obtained in a similar manner and their molecular structures have been determined by X-ray diffraction analysis. The cytotoxicities of the mono- and multinuclear complexes were established using A2780 and A2780cisR human ovarian carcinoma cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21165516     DOI: 10.1039/c0dt00761g

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  10 in total

1.  Coordination-driven self-assembly of ruthenium-based molecular-rectangles: synthesis, characterization, photo-physical and anticancer potency studies.

Authors:  Vaishali Vajpayee; Young Ho Song; Young Jun Jung; Se Chan Kang; Hyunuk Kim; In Su Kim; Ming Wang; Timothy R Cook; Peter J Stang; Ki-Whan Chi
Journal:  Dalton Trans       Date:  2012-01-26       Impact factor: 4.390

2.  Metal-containing and related polymers for biomedical applications.

Authors:  Yi Yan; Jiuyang Zhang; Lixia Ren; Chuanbing Tang
Journal:  Chem Soc Rev       Date:  2016-02-24       Impact factor: 54.564

3.  Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.

Authors:  Lotta Glans; Andreas Ehnbom; Carmen de Kock; Alberto Martínez; Jesús Estrada; Peter J Smith; Matti Haukka; Roberto A Sánchez-Delgado; Ebbe Nordlander
Journal:  Dalton Trans       Date:  2012-01-17       Impact factor: 4.390

4.  Impact of various lipophilic substituents on ruthenium(II), rhodium(III) and iridium(III) salicylaldimine-based complexes: synthesis, in vitro cytotoxicity studies and DNA interactions.

Authors:  Irwin Cassells; Tameryn Stringer; Alan T Hutton; Sharon Prince; Gregory S Smith
Journal:  J Biol Inorg Chem       Date:  2018-05-30       Impact factor: 3.358

Review 5.  Ruthenium(ii)-arene complexes as anti-metastatic agents, and related techniques.

Authors:  Chanchal Sonkar; Sayantan Sarkar; Suman Mukhopadhyay
Journal:  RSC Med Chem       Date:  2021-09-15

6.  Growth Inhibitory Activity of a Bis-benzimidazole-Bridged Arene Ruthenium Metalla-Rectangle and Prism.

Authors:  Vaishali Vajpayee; Sun Mi Lee; Joeng Woo Park; Abhishek Dubey; Hyunuk Kim; Timothy R Cook; Peter J Stang; Ki-Whan Chi
Journal:  Organometallics       Date:  2013-03-25       Impact factor: 3.876

7.  Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes.

Authors:  Marta Maroto-Díaz; Benelita T Elie; Pilar Gómez-Sal; Jorge Pérez-Serrano; Rafael Gómez; María Contel; F Javier de la Mata
Journal:  Dalton Trans       Date:  2016-04-28       Impact factor: 4.390

8.  Poly(alkylidenimine) Dendrimers Functionalized with the Organometallic Moiety [Ru(η⁵-C₅H₅)(PPh₃)₂]⁺ as Promising Drugs Against Cisplatin-Resistant Cancer Cells and Human Mesenchymal Stem Cells.

Authors:  Marisol Gouveia; João Figueira; Manuel G Jardim; Rita Castro; Helena Tomás; Kari Rissanen; João Rodrigues
Journal:  Molecules       Date:  2018-06-17       Impact factor: 4.411

9.  Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.

Authors:  Sylwia Michlewska; Małgorzata Kubczak; Marta Maroto-Díaz; Natalia Sanz Del Olmo; Paula Ortega; Dzmitry Shcharbin; Rafael Gomez Ramirez; Francisco Javier de la Mata; Maksim Ionov; Maria Bryszewska
Journal:  Biomolecules       Date:  2019-08-25

10.  Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compounds.

Authors:  Shyam Sunder A; Satyavati Dhulipala; Sreekanth Thota; Rajeshwar Yerra; Jan Balzarini; Erik De Clercq
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.